Pharmacogenetics

Ryan Nelson, PharmD, received a Double Helix Award for his work on MetaCensus during the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Annual Meeting and Consensus Workshop.

Medical Director Ryan Nelson, PharmD, will moderate a STRIPE Annual Meeting workshop in October focused on building consensus around standards for integrating personalized medicine into healthcare.

MetaCensus is the first open-access data repository built for peer-review and meta-analysis. The tool aims to break down stakeholder silos to quickly achieve scientific consensus.

ARUP medical directors and scientists will discuss the latest in pharmacogenomics, RNA sequencing, and laboratory genetics career pathways at the upcoming ACMG Annual Clinical Genetics Meeting.

ARUP Laboratories Senior Pharmacy Consultant Ryan Nelson, PharmD, is on a quest to share how underused pharmacogenomic testing can help identify and enable guideline-supported therapies.

ARUP Laboratories announced today that the Food and Drug Administration (FDA) has filed ARUP’s premarket approval application (PMA) for an AAV5 total antibody assay.

Pharmacogenetics (PGx) is an area of testing that assesses the genes that affect the body’s response to medications.

Rheumatoid arthritis (RA) is an autoimmune disease, more specifically a noninfectious inflammatory disease. Inflammation results from the overproduction of several proteins in the body.

Adverse drug reactions cause more than 700,000 ER visits each year, with some 120,000 patients needing to be hospitalized for further treatment, according to the CDC.